Driven by the rising prevalence of gastrointestinal (GI) cancers and increasing demand for minimally invasive treatment options, the adoption of advanced endoscopic technologies continues to grow globally. Reflecting this trend, Japan’s endoscopy market is expected to witness steady expansion at 4% CAGR through 2036, supported by growing preference for minimally invasive interventions and steady technological advancement in endotherapy systems, forecasts GlobalData, a leading intelligence and productivity platform.
GlobalData’s report, “Endoscopy Visualization Systems and Components Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036” reveals that increasing physician preference for minimally invasive GI procedures, alongside technological advancements and procedural applications, is contributing to the wider utilization of advanced endotherapy systems across major healthcare markets.
In this context, Japan-based Olympus has signed a global distribution agreement with South Korea-based EndoRobotics to further expand Olympus robotic-assisted endoscopy capabilities through its EndoTherapy portfolio. The partnership aims to support advanced endoscopic procedures such as endoscopic submucosal dissection (ESD), enabling clinicians to perform complex minimally invasive procedures with greater precision and efficiency.
Anindita Ghosh, Medical Devices Analyst at GlobalData, comments: “The integration of robotic-assisted technologies into therapeutic endoscopy represents an advancement in minimally invasive gastrointestinal care. As healthcare providers increasingly prioritize precision-driven and organ-preserving treatment approaches, collaborations such as the Olympus-EndoRobotics agreement are expected to accelerate adoption of advanced endoscopic procedures globally.”
The ongoing advancements in endoscopy technologies, including robotic-assisted navigation systems and next-generation therapeutic platforms, continue to enhance procedural capabilities across minimally invasive interventions. An increasing emphasis on precision-driven workflows, improved operator control, and enhanced visualization are supporting the broader adoption of technologically advanced endoscopic systems in complex therapeutic procedures.
Ghosh concludes: “Robot-assisted therapeutic endoscopy technologies are expected to play an increasingly important role in the future of gastrointestinal disease management. While adoption may vary across regions depending on reimbursement frameworks, training availability, and regulatory pathways, ongoing technological advancements and strategic industry collaborations are likely to drive broader commercialization and clinical acceptance in the coming years.”
